New Alzheimer's drug J4 enters first human safety tests
NCT ID NCT06938763
First seen Jan 08, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This early-stage trial tests whether a new oral drug called J4 is safe for people. It involves 76 healthy adults aged 18 to 64. Researchers will give single and multiple doses to see how the body handles the drug and if any side effects occur. This study does not treat Alzheimer's directly but gathers important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taipei Medical University Hospital
RECRUITINGTaipei, 110, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.